Bio Solution Co.,Ltd. (KOSDAQ:086820)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,950.00
-400.00 (-4.28%)
At close: Feb 27, 2026
-5.12%
Market Cap 216.34B
Revenue (ttm) 8.27B
Net Income (ttm) -1.28B
Shares Out 24.17M
EPS (ttm) -53.69
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 176,062
Average Volume 239,468
Open 9,270.00
Previous Close 9,350.00
Day's Range 8,900.00 - 9,650.00
52-Week Range 7,050.00 - 13,200.00
Beta 0.35
RSI 57.48
Earnings Date Mar 17, 2026

About Bio Solution

Bio Solution Co.,Ltd. develops, manufactures, and sells cell therapy products worldwide. The company offers CartiLife, an autologous chondrocyte cell-based therapy for the restoration of symptomatic and structural complications caused by articular cartilage defects; KeraHeal-Allo, a thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product to promote re-epithelialization of deep 2nd-degree burn wounds; and KeraHeal, an autologous spray-type keratinocyte cell-based therapy for skin wounds. It also provides reconstructed human mic... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 71
Stock Exchange KOSDAQ
Ticker Symbol 086820
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.